Patient dies by suicide after "insurance issue" delayed medicine for lung disease flare-ups

Key Points:

• Kenney Blewett, diagnosed with lung disease and COPD, experienced worsening symptoms in 2025 but faced delays in receiving a prescribed medication due to insurance and prior authorization issues, contributing to his deteriorating health.
• The prescription delay was linked to confusion over Medicare Part B versus Part D coverage and missing diagnostic codes, with Walgreens and the pulmonologist's office providing conflicting information about the authorization process.
• Insurance delays and denials remain a widespread problem in the U.S. healthcare system, despite voluntary pledges by major insurers to reduce barriers, and the complexity is expected to increase with the introduction of AI in prior authorization processes.
• Blewett's wife, Cindy, struggled to navigate the complicated insurance landscape and remains uncertain about who was responsible for the delay, which she believes may have contributed to Kenney's suicide following a severe COPD flare-up.
• The case highlights the challenges patients face with insurance red tape, the need for clearer regulations, and better support for individuals managing chronic conditions amid a fragmented healthcare system.